France CAC 40 Sees Mixed Performance, Sanofi and Dassault Systèmes SA Lead Gains and Losses

Apr 25 2024 05:01 PM IST
Today's market is showing a mixed performance, with one sector advancing and one sector declining. The France CAC 40 index is the top losing sector, down by 0.93%. On the other hand, individual stocks such as Sanofi, Bureau Veritas SA, and Getlink SE are among the top gainers. The advance-decline ratio for France CAC 40 is currently at 0.49x, indicating a slightly bearish sentiment. Some of the top gainers in the index include Colipays Réunion, Imalliance SA, and Cnova NV, while Acticor Biotech SAS, Uniti SA, and Biosynex SA are among the top losers. Overall, the market is experiencing a mix of positive and negative factors, resulting in a relatively flat performance. Investors should closely monitor individual stocks and sectors for informed decision-making.




The market is seeing a mixed performance today, with 1 sector advancing and 1 sector declining. The top losing sector is France CAC 40, which is down by 0.93%. This index is currently trading at 8,016.65 with a loss of 75.21 points.

In terms of individual stocks, Sanofi is the top gainer in the large cap category with a 4.47% increase, followed by Bureau Veritas SA in the mid cap category with a 1.56% gain, and Getlink SE in the small cap category with a 1.39% increase. On the other hand, Dassault Systèmes SA is the top loser in the large cap category with a 4.24% decrease, Sartorius Stedim Biotech SA in the mid cap category with a 2.35% loss, and Teleperformance SE in the small cap category with a 2.69% decline.

The advance-decline ratio for France CAC 40 is currently at 0.49x, with 158 advances and 321 declines. This indicates a slightly bearish sentiment in the market.

Some of the top gainers in the France CAC 40 index include Colipays Réunion with a 32.46% increase, Imalliance SA with a 29.03% gain, and Cnova NV with a 23.97% rise. On the other hand, the top losers include Acticor Biotech SAS with a staggering 92.64% decrease, Uniti SA with a 24.44% loss, and Biosynex SA with a 23.13% decline.

Overall, the market is being driven by a mix of positive and negative factors, resulting in a relatively flat performance. Investors should closely monitor the performance of individual stocks and sectors to make informed decisions.

Loading...
{{stock_short.stock.price.value}}
{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)
WHY IT'S
{{stock_short.dot_summary.scoreText}}

MOJO SCORE

{{stock_short.dot_summary.score}}
{{key}}
{{stock_short.stock.stock_name.value}}
{{stock_short.stock.price.value}}
{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)
{{ra.field}}
{{ra.stock_return.chgp}}%
{{ra.sensex_return.chgp}}%
{{stock_short.result_details[0].header}}
{{stock_short.result_details[0].latest.to_period}}
{{stock_short.result_details[0].latest.from_period}}
Change%
{{latest.field}}
{{latest.to}}{{latest.value_suffix}}
{{latest.from}}{{latest.value_suffix}}
{{latest.per}}
Figures in Rs cr
Mojo Parameters
Quality: {{stock_short.dashboard.dotsummary.q_txt}}
Valuation: {{stock_short.dashboard.dotsummary.v_txt}}
Quarterly Financial Trend: {{stock_short.dashboard.dotsummary.f_txt}}
Technicals: {{stock_short.dashboard.dotsummary.tech_txt}}
Stock Info
Market Cap: {{stock_short.stock_data[1]['value']}}
Sector:{{stock_short.stock_data[0]['value']}}
52 w H/L (Rs.):{{stock_short.dashboard.priceinfo['52wk_high']}}/{{stock_short.dashboard.priceinfo['52wk_low']}}

Related News